Physician profile
Anna Leggett
NPI 1942495023
$4,241.00
in general payments reported to CMS, 2019-2025
13 companies · $707 in 2025
The $707 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $326 · 2021: $323 · 2022: $673 · 2023: $786 · 2024: $825 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,318.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,843.20 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $1,073.44 | 2019-2025 | Acuvue |
| Coopervision INC. | $496.67 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $400.31 | 2022-2025 | Infuse, Biotrue One Day |
| Abbvie INC. | $123.37 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $117.02 | 2019-2021 | |
| Rxsight INC | $57.69 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens |
| Aerie Pharmaceuticals, INC. | $37.12 | 2019 | |
| Thea Pharma INC. | $34.37 | 2023 | |
| Dompe US, INC. | $19.67 | 2022 | |
| Oyster Point Pharma, INC. | $13.40 | 2022 | |
| Sun Pharmaceutical Industries INC. | $13.12 | 2020 | |
| Allergan, INC. | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Leggett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.